Physician profile
Roxana E Araujo
NPI 1992053367
$2,090.52
in general payments reported to CMS, 2019-2025
21 companies · $541 in 2025
The $541 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $169 · 2022: $85.51 · 2023: $217 · 2024: $1,078 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169 · Travel and Lodging: $622 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.75 |
| Travel and Lodging | $621.82 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $809.53 | 2022-2024 | Synchromedii, Intellis Adaptivestim, Accurian |
| Boston Scientific Corporation | $311.33 | 2021-2025 | Wavewriter Alpha Prime 16, General - Erectile Dysfunction |
| Collegium Pharmaceutical, INC. | $244.70 | 2021-2025 | Belbuca, Xtampza |
| Pacira Pharmaceuticals Incorporated | $127.98 | 2023 | Iovera, Exparel, Zilretta |
| Endo Pharmaceuticals INC. | $106.96 | 2022-2023 | Xiaflex |
| Pfizer INC. | $98.77 | 2021-2025 | |
| Saluda Medical Americas, INC. | $62.38 | 2024-2025 | Evoke |
| Abbvie INC. | $43.90 | 2021 | |
| Averitas Pharma INC. | $34.74 | 2024 | Qutenza |
| Tonix Medicines, INC. | $31.43 | 2025 | Tonmya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.70 | 2021 | |
| Globus Medical, INC. | $26.56 | 2025 | Senza |
| Nevro Corp. | $25.28 | 2024 | Senza |
| Biotronik Nro, INC. | $23.87 | 2025 | Prospera |
| Nalu Medical, INC. | $20.22 | 2024 | Nalu Neurostimulation System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.40 | 2024 | Eterna |
| Kowa Pharmaceuticals America, INC. | $18.27 | 2023 | Seglentis |
| Biodelivery Sciences International, INC. | $17.11 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.77 | 2022 | |
| Scilex Pharmaceuticals INC. | $14.55 | 2021 | |
| Painteq LLC | $13.07 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxana Araujo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.